New confidence bounds for QT studies

Statistics in Medicine

Volumn 26, Issue 20, 2007, Pages 3801-3817

  Boos, Dennis D ^a   Hoffman, David ^b   Kringle, Robert ^b   Zhang, Ji ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Global Health Outcomes and Market Access   (United States)

Author keywords

Arrhythmia; Crossover; Electrocardiogram; Parallel design; Repolarization

Indexed keywords

ARTICLE; BOOTSTRAPPING; CALCULATION; DRUG RESEARCH; ELECTROCARDIOGRAPHY; FALSE POSITIVE RESULT; HEART ARRHYTHMIA; HEART REPOLARIZATION; MONTE CARLO METHOD; NONPARAMETRIC TEST; PARALLEL DESIGN; QRS COMPLEX; QT INTERVAL; RANDOM ERROR; STATISTICAL DISTRIBUTION; T WAVE;

ALGORITHMS; ARRHYTHMIA; CROSS-OVER STUDIES; DRUG EVALUATION; ELECTROCARDIOGRAPHY; HUMANS; PHARMACEUTICAL PREPARATIONS; UNITED STATES;

EID: 34548166011     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2826     Document Type: Article

References (5)

1. Food and Drug Administration. Guidance for Industry: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrythmic Potential for Non-Antiarrythmic Drugs, U.S. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, October 2005.
2. Efron B, Tibshirani R. An Introduction to the Bootstrap. Chapman & Hall: London, 1993.
3. Efron B. Better bootstrap confidence intervals. Journal of the American Statistical Association 1987; 82:171-185.
4. DiCiccio TJ, Efron B. Bootstrap confidence intervals. Statistical Science 1996; 11:189-228.
5. Eaton ML, Muirhead RJ, Mancuso JY, Kolluri S. A confidence interval for the maximal mean QT interval change caused by a drug effect. Drug Information Journal 2006; 40:267-271.